Bredent medical presents minimally invasive ultrashort implant
LONDON, UK: German dental implants company bredent medical has introduced the copaSKY ultrashort implant system which offers an alternative to standard dental implants and not only reduces costs—as a result of eradicating the need to build up the bone through augmentation or sinus lift procedures—but also offers a less invasive route to restoration. The possibility of avoiding risky surgical procedures for bone augmentation in numerous clinical indications makes the copaSKY ultrashort a go-to choice from the patient’s perspective for the replacement of missing teeth. It makes the whole treatment more affordable and eliminates the need for discussions about patients’ aversion to extensive surgeries.
Having a length of only 5.2 mm and a diameter of 4.0, 4.5, 5.0 or 6.0 mm, the copaSKY ultrashort implant makes it possible to utilise the available native bone optimally. It creates a stable basis for an implant-supported restoration, even under the most challenging of conditions. Indeed, the ultrashort implant system lessens the risk of damaging vital structures such as nerves and blood vessels.
Award-winning Dr Marcus Gambroudes has placed over 4,000 implants and trains and mentors other dentists about complex implant cases. He will lecture and conduct a hands-on practical session at the ADI Team Congress in 2022, demonstrating why bredent medical copaSKY is a real practice builder. He said: “I am impressed by the clinical applications of the copaSKY implant range. I use it for the versatility of the implant for placement in areas of limited bone height, as well as for immediate placement in extraction sockets and full-arch immediate load.”
Prof. Emanuel Bratu, who was the first oral surgeon to test the copaSKY and who has been using it for over three years, commented: “I mostly use the 5.2 mm copaSKY ultrashort dental implants from bredent medical. They work well for the maxillae and mandibles where they provide very good support. In extremely resorbed posterior regions, you can use two or three of these implants splinted together and the long-term results are very satisfactory. There is no bone loss and there is good soft tissue healing around it because of the conical connections of the implant—that applies both for the ultrashort and regular copaSKY.”
Having a wide range of prosthetic options is essential for successful treatment outcomes in implant dentistry. The copaSKY range offers all the necessary solutions for conventional and digital workflows, from screw-retained to cemented restorations and from single-tooth to full-arch restorations.
The patented copaSKY elegance hybrid abutment, which is a ceramic reinforced high-performance polymer abutment, injection-moulded on a titanium base, has a shock-absorbing capacity which ensures the long-term safety of the ultrashort implant because it reduces the maximum forces transferred to the implant.
The company’s copaSKY implants also have the tried and tested osseo connect surface which has enabled SKY implants to set milestones in recent decades in immediate restoration. Optimum use of the available bone is ensured thanks to both the implant design and the bone-oriented surgical protocol, which means that high primary stability and complete osseointegration are guaranteed. In this way, both traumatic stress for patients and the number of treatment sessions can be significantly reduced.
Aesthetically sophisticated, bredent’s copaSKY ultrashort implants are an ideal option when there is not enough bone above the inferior alveolar nerve and sinuses. They are the preferred choice for the surgery-phobic patient and for those wishing to restore their smile in an affordable and less time-consuming way. For more information about bredent’s copaSKY ultrashort implant system, please visit www.bredent.co.uk.